Thus far, insulin administration remains the cornerstone of DM management [50], and earlier studies have shown that insulin therapy could dominate blood sugar and ameliorate bone regeneration of implants for diabetics [1, 51, 52]. The gene discussed is INS; the disease is diabetes mellitus.